Sarcoidosis in the Middle East
Sarcoidosis, a systemic granulomatous disease of unknown cause, has been described worldwide and in all populations with notable differences in clinical characteristics, organ involvement, disease severity, and prognosis among different ethnic and racial groups. While the exact prevalence of sarcoid...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Annals of Thoracic Medicine |
Subjects: | |
Online Access: | http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2019;volume=14;issue=2;spage=106;epage=115;aulast=Jayakrishnan |
_version_ | 1828399474540544000 |
---|---|
author | B Jayakrishnan Nasser Al-Busaidi Saif Al-Mubaihsi Omar A Al-Rawas |
author_facet | B Jayakrishnan Nasser Al-Busaidi Saif Al-Mubaihsi Omar A Al-Rawas |
author_sort | B Jayakrishnan |
collection | DOAJ |
description | Sarcoidosis, a systemic granulomatous disease of unknown cause, has been described worldwide and in all populations with notable differences in clinical characteristics, organ involvement, disease severity, and prognosis among different ethnic and racial groups. While the exact prevalence of sarcoidosis in the Middle East is unknown, studies from various countries in the region have reported the clinical characteristics of affected patients, along with a few anecdotal reports. A search of the MEDLINE and Google Scholar databases was conducted for relevant English-language articles using the terms “sarcoidosis” and “Middle East” or “sarcoidosis” and “Arabs.” Subsequently, the names of individual countries were used as search terms, replacing “Middle East.” Overall, the clinical picture of patients with sarcoidosis in the Middle East is similar to that reported elsewhere; for example, the disease was more frequent among females and respiratory complaints were the predominant symptoms. Within the region, most patients from Oman were older and female, with arthralgia, hypercalcemia, and eye involvement being more common. Constitutional symptoms were frequent, especially among patients from Iran. Cough was more common among patients from Kuwait and Iran, while dyspnea was the predominant symptom for Saudi patients. Erythema nodosum was more common in the Turkish population. Clustering was seen in patients with Stage I and II of the disease in all countries except Oman. Apart from those in Iran, the prognosis of most patients from the Middle East was excellent. |
first_indexed | 2024-12-10T09:17:11Z |
format | Article |
id | doaj.art-8f3f9dccc92940a8a08f817ed9a0c49f |
institution | Directory Open Access Journal |
issn | 1817-1737 1998-3557 |
language | English |
last_indexed | 2024-12-10T09:17:11Z |
publishDate | 2019-01-01 |
publisher | Wolters Kluwer Medknow Publications |
record_format | Article |
series | Annals of Thoracic Medicine |
spelling | doaj.art-8f3f9dccc92940a8a08f817ed9a0c49f2022-12-22T01:54:48ZengWolters Kluwer Medknow PublicationsAnnals of Thoracic Medicine1817-17371998-35572019-01-0114210611510.4103/atm.ATM_227_18Sarcoidosis in the Middle EastB JayakrishnanNasser Al-BusaidiSaif Al-MubaihsiOmar A Al-RawasSarcoidosis, a systemic granulomatous disease of unknown cause, has been described worldwide and in all populations with notable differences in clinical characteristics, organ involvement, disease severity, and prognosis among different ethnic and racial groups. While the exact prevalence of sarcoidosis in the Middle East is unknown, studies from various countries in the region have reported the clinical characteristics of affected patients, along with a few anecdotal reports. A search of the MEDLINE and Google Scholar databases was conducted for relevant English-language articles using the terms “sarcoidosis” and “Middle East” or “sarcoidosis” and “Arabs.” Subsequently, the names of individual countries were used as search terms, replacing “Middle East.” Overall, the clinical picture of patients with sarcoidosis in the Middle East is similar to that reported elsewhere; for example, the disease was more frequent among females and respiratory complaints were the predominant symptoms. Within the region, most patients from Oman were older and female, with arthralgia, hypercalcemia, and eye involvement being more common. Constitutional symptoms were frequent, especially among patients from Iran. Cough was more common among patients from Kuwait and Iran, while dyspnea was the predominant symptom for Saudi patients. Erythema nodosum was more common in the Turkish population. Clustering was seen in patients with Stage I and II of the disease in all countries except Oman. Apart from those in Iran, the prognosis of most patients from the Middle East was excellent.http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2019;volume=14;issue=2;spage=106;epage=115;aulast=JayakrishnanArabsMiddle Eastsarcoidosis |
spellingShingle | B Jayakrishnan Nasser Al-Busaidi Saif Al-Mubaihsi Omar A Al-Rawas Sarcoidosis in the Middle East Annals of Thoracic Medicine Arabs Middle East sarcoidosis |
title | Sarcoidosis in the Middle East |
title_full | Sarcoidosis in the Middle East |
title_fullStr | Sarcoidosis in the Middle East |
title_full_unstemmed | Sarcoidosis in the Middle East |
title_short | Sarcoidosis in the Middle East |
title_sort | sarcoidosis in the middle east |
topic | Arabs Middle East sarcoidosis |
url | http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2019;volume=14;issue=2;spage=106;epage=115;aulast=Jayakrishnan |
work_keys_str_mv | AT bjayakrishnan sarcoidosisinthemiddleeast AT nasseralbusaidi sarcoidosisinthemiddleeast AT saifalmubaihsi sarcoidosisinthemiddleeast AT omaraalrawas sarcoidosisinthemiddleeast |